Overview
Financials
Revenue history (in k)
Financial insight
- Estonian CIT: Equity includes non-zero Art. 28d line items – the company is taxed under the lump-sum regime on corporate income.
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 108 days for 2024). 2 of 6 audited by a statutory auditor.
- 202502/10/2026
- 202431/10/2025
- 202320/06/2024
- 202229/06/2023
- 202113/10/2022
- 202029/09/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
National Health Fund (NFZ) contracts
Remedium.Ch has been an NFZ healthcare provider since 2024. In 2026 it is performing 2 contracts with a total value of USD 44.44k. All its contracts were worth USD 113.99k in total.
NFZ contract value by year (in k USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Other services provided in pharmacies | małopolskie | 1 | USD 44.44k |
| Provision of medical devices | małopolskie | 1 | USD 0.00 |
Authorized Representatives
Manner of representation
In the case of a multi-member management board, the President of the Management Board independently, or two members of the management board acting jointly, is authorized to make declarations concerning the company's property and non-property rights and obligations. If an independent commercial proxy is appointed, the commercial proxy is authorized to independently make declarations concerning the company's property and non-property rights.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Marzena Katarzyna Włodarczykage 46 | 1,100 | $29,713.67 | 10% |
Przemysław Włodarczykage 48 | 9,900 | $267,423.01 | 90% |
Przemysław Włodarczyk and Marzena Katarzyna Włodarczyk hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2017-05-17.
30 1050 1445 1000 0090 3287 0850
54 1600 1462 1841 5244 4000 0001
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 22, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Małopolska Agencja Rozwoju Regionalnego S.A. | |
| Jun 18, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Polski Fundusz Rozwoju S.A. | |
| Nov 9, 2017 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Prezes Banku Gospodarstwa Krajowego |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Apis Farmacjasp. z o.o. | $14,614,704.02 | apisapteka.pl | ||
| Przedsiębiorstwo Zaopatrzenia Farmaceutycznego Cefarm-KielceS.A. | $11,363,887.49 | farmacol.com.pl | ||
| MybestpharmS.A. | $10,884,130.91 | mybestpharm.pl | ||
| Fragalsp. z o.o. | $5,374,285.81 | aptekafragal.pl | ||
| Modrzewscysp. j. | $5,602,358.99 | aptekacentrum.lublin.pl | ||
| Adpharmasp. z o.o. | $5,595,917.60 | adamed.com | ||
| Ms-Pharmsp. z o.o. + limited partnership | $4,619,501.46 | mspharm.pl | ||
| MagmaxS.A. | $4,574,562.64 | magmaxsa.pl | ||
| Farmjug Agsp. z o.o. | $4,213,734.86 | farmjug.pl | ||
| Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j. | $3,414,382.70 | aptekazielona.com.pl |
Change history
| Date | Event | |
|---|---|---|
| 2017-07-24 | Share capital increase (1,000,000.00 PLN → 1,100,000.00 PLN) | |
| 2017-05-12 | Entered in the register |
FAQ
Last updated: 2026-10-02